IQVIA Names AWS as Preferred Agentic Cloud Provider to Advance Next-Generation AI Platform

The collaboration underscores a shift toward cloud-powered agentic AI in life sciences, with a focus on strengthening efficiency, accelerating innovation and improving patient outcomes.

IQVIA has announced a strategic collaboration with Amazon Web Services (AWS), naming AWS as the company’s Preferred Agentic Cloud Provider.

The partnership marks a significant step in the digital transformation of healthcare and life sciences, with a focus on advancing clinical trial automation, medical affairs and analytics through IQVIA’s agentic AI platform.

Under the agreement, IQVIA will deploy its AI platform on AWS to enable scalable, secure and intelligent automation across clinical trial execution, medical affairs and healthcare analytics. The collaboration is intended to improve clinical trial automation, accelerate processes and expand the scope of data-driven insights for life sciences.

IQVIA and AWS will also explore new opportunities in life science analytics to support next-generation solutions. With 90% of the world’s largest pharmaceutical companies relying on both organizations for digital transformation and analytics, the collaboration aims to democratize AI, accelerate drug development and support faster delivery of treatments.

"We are excited to move forward with AWS as IQVIA’s Preferred Agentic Cloud Provider. Our AI platform aims to empower life sciences organizations to innovate faster and deliver treatments to patients more efficiently," said Lucas Glass, SVP, Architecture and Standards at IQVIA. "With agentic AI, we will unlock new possibilities for our clients and the industry at large."

“We are thrilled to support IQVIA’s Agentic AI platform with the full breadth of AWS’s cloud capabilities,” said Allyson Fryhoff, director of global healthcare and life sciences at Amazon Web Services. “Together, we aim to help the life sciences industry leverage the power of AI to support ongoing innovation in healthcare and achieve outcomes once thought impossible.”

The collaboration underscores a shift toward cloud-powered agentic AI in life sciences, with a focus on strengthening efficiency, accelerating innovation and improving patient outcomes.

Stay tuned for more such updates on Digital Health News